Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy
Barkmeier A, Herrin J, Swarna K, Deng Y, Polley E, Umpierrez G, Galindo R, Ross J, Mickelson M, McCoy R. Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy. Ophthalmology Retina 2024, 8: 943-952. PMID: 38735641, DOI: 10.1016/j.oret.2024.05.003.Peer-Reviewed Original ResearchEffects of GLP-1 receptor agonistsSight-threatening diabetic retinopathyGLP-1 receptor agonistsDPP-4 inhibitorsReceptor agonistsDiabetic retinopathySGLT2 inhibitorsDPP-4